Verge CBO, Jane Rhodes, PhD, to participate in Fierce Biotech Summit Panel

Verge Genomics Chief Business Officer, Jane Rhodes, will participate as a panel member during the Fierce Biotech Summit on Tuesday September 20, 2022.

Leverage AI and ML to Advance Discovery and Accelerate Drug Development
Developing a therapeutic on average takes 12+ years and billions of dollars, but now with AI and machine learning, the potential to identify molecules and bring them to the clinic faster and cheaper can be a reality. But where has there been proven success applying AI and ML and does it live up to the hype?